Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
32,140,688
-
Share change
-
+17,559,906
-
Total reported value
-
$1,514,142,962
-
Put/Call ratio
-
30%
-
Price per share
-
$47.11
-
Number of holders
-
98
-
Value change
-
+$871,757,330
-
Number of buys
-
75
-
Number of sells
-
14
Institutional Holders of CONSTELLATION PHARMCETICLS I - COM (CNST) as of Q4 2019
As of 31 Dec 2019,
CONSTELLATION PHARMCETICLS I - COM (CNST) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,140,688 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, TRV GP, LLC, Bain Capital Life Sciences Investors, LLC, VHCP Management III, LLC, Cormorant Asset Management, LP, WELLINGTON MANAGEMENT GROUP LLP, REGENTS OF THE UNIVERSITY OF CALIFORNIA, FMR LLC, VHCP Management II, LLC, and Casdin Capital, LLC.
This page lists
98
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.